Effectdossier · gearchiveerd kwartaal
IOVA
Iovance Biotherapeutics, Inc. · Healthcare · Biotechnology
98Gevolgde houders
+1Δ houders
178.19MGehouden aandelen
$486.45MGerapporteerde waarde
+1Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +1.0% ·
aandelenstroom +18.3% ·
netto nieuwe posities +1.0%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | +5 | 196.52M | $817.32M | +8 | −3 |
| Q1 2026 | 101 | +2 | 181.45M | $636.15M | +8 | −6 |
| Q4 2025 | 98 | +1 | 178.19M | $486.45M | +1 | — |
| Q3 2025 | 14 | -2 | 98.05M | $212.78M | — | −2 |
| Q2 2025 | 13 | -2 | 89.90M | $154.64M | — | −2 |
| Q1 2025 | 12 | +2 | 25.73M | $85.68M | +2 | — |
| Q4 2024 | 10 | 0 | 23.63M | $174.86M | +2 | −2 |
| Q3 2024 | 9 | -1 | 11.04M | $103.72M | +1 | −2 |
| Q2 2024 | 10 | — | 13.79M | $110.63M | — | — |
Wie het bezit · Q4 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 29.52M | +13.7% | $80.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 27.21M | +13.1% | $74.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 27.21M | +13.1% | $74.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 27.21M | +13.1% | $74.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 27.21M | +13.1% | $74.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 27.21M | +13.1% | $74.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passief) | 20.16M | +51.5% | $55.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Bank Of America Corp /De/ | 14.28M | — | $38.98M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Bank Of America Corp /De/ | 14.28M | — | $38.98M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bank Of America Corp /De/ | 14.28M | — | $38.98M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Bank Of America Corp /De/ | 14.28M | — | $38.98M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 9.19M | +64.7% | $25.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 9.19M | +64.7% | $25.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 9.19M | +64.7% | $25.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 9.19M | +64.7% | $25.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 9.19M | +64.7% | $25.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 9.19M | +64.7% | $25.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 9.19M | +64.7% | $25.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 32 | Goldman Sachs Group ✦ | 8.61M | +30.9% | $23.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 33 | Goldman Sachs Group ✦ | 8.61M | +30.9% | $23.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 34 | Goldman Sachs Group ✦ | 8.61M | +30.9% | $23.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 35 | Geode Capital Management ✦ (passief) | 7.99M | +16.4% | $21.82M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 36 | Geode Capital Management ✦ (passief) | 7.99M | +16.4% | $21.82M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 37 | Millennium Management ✦ | 6.59M | +49.2% | $17.98M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 38 | Susquehanna International Group, Llp | 4.95M | — | $13.51M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Two Sigma Investments ✦ | 4.40M | +60.5% | $12.01M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 40 | Hrt Financial Lp | 4.36M | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | D. E. Shaw & Co. ✦ | 3.83M | +4925.4% | $10.46M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 42 | Jane Street Group, Llc | 3.58M | — | $9.78M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Jane Street Group, Llc | 3.58M | — | $9.78M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Jane Street Group, Llc | 3.58M | — | $9.78M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Citadel Advisors ✦ | 3.14M | -17.7% | $8.58M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 3.00M | +22.6% | $8.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 3.00M | +22.6% | $8.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 3.00M | +22.6% | $8.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 3.00M | +22.6% | $8.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 3.00M | +22.6% | $8.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 51 | Charles Schwab Investment… | 2.75M | — | $7.52M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Northern Trust Corp | 2.58M | — | $7.04M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | Northern Trust Corp | 2.58M | — | $7.04M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | Northern Trust Corp | 2.58M | — | $7.04M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Northern Trust Corp | 2.58M | — | $7.04M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Northern Trust Corp | 2.58M | — | $7.04M | 0.0% | n/c | 1 | SEC ↗ |
| 57 | Wells Fargo & Company/Mn | 1.99M | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 58 | Wells Fargo & Company/Mn | 1.99M | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 59 | Wells Fargo & Company/Mn | 1.99M | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 60 | Dimensional Fund Advisors Lp | 1.54M | — | $4.20M | 0.0% | n/c | 1 | SEC ↗ |
| 61 | Dimensional Fund Advisors Lp | 1.54M | — | $4.20M | 0.0% | n/c | 1 | SEC ↗ |
| 62 | Dimensional Fund Advisors Lp | 1.54M | — | $4.20M | 0.0% | n/c | 1 | SEC ↗ |
| 63 | Dimensional Fund Advisors Lp | 1.54M | — | $4.20M | 0.0% | n/c | 1 | SEC ↗ |
| 64 | Dimensional Fund Advisors Lp | 1.54M | — | $4.20M | 0.0% | n/c | 1 | SEC ↗ |
| 65 | Nuveen, LLC | 1.39M | — | $3.78M | 0.0% | n/c | 1 | SEC ↗ |
| 66 | Nuveen, LLC | 1.39M | — | $3.78M | 0.0% | n/c | 1 | SEC ↗ |
| 67 | Nuveen, LLC | 1.39M | — | $3.78M | 0.0% | n/c | 1 | SEC ↗ |
| 68 | Invesco Ltd. | 1.25M | — | $3.42M | 0.0% | n/c | 1 | SEC ↗ |
| 69 | Invesco Ltd. | 1.25M | — | $3.42M | 0.0% | n/c | 1 | SEC ↗ |
| 70 | Invesco Ltd. | 1.25M | — | $3.42M | 0.0% | n/c | 1 | SEC ↗ |
| 71 | Invesco Ltd. | 1.25M | — | $3.42M | 0.0% | n/c | 1 | SEC ↗ |
| 72 | T. Rowe Price ✦ | 1.19M | -42.1% | $3.25M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 73 | T. Rowe Price ✦ | 1.19M | -42.1% | $3.25M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 74 | Barclays Plc | 1.13M | — | $3.08M | 0.0% | n/c | 1 | SEC ↗ |
| 75 | Barclays Plc | 1.13M | — | $3.08M | 0.0% | n/c | 1 | SEC ↗ |
| 76 | Barclays Plc | 1.13M | — | $3.08M | 0.0% | n/c | 1 | SEC ↗ |
| 77 | Bank of New York Mellon Corp | 955.47K | — | $2.61M | 0.0% | n/c | 1 | SEC ↗ |
| 78 | Bank of New York Mellon Corp | 955.47K | — | $2.61M | 0.0% | n/c | 1 | SEC ↗ |
| 79 | Bank of New York Mellon Corp | 955.47K | — | $2.61M | 0.0% | n/c | 1 | SEC ↗ |
| 80 | Bank of New York Mellon Corp | 955.47K | — | $2.61M | 0.0% | n/c | 1 | SEC ↗ |
| 81 | Bank of New York Mellon Corp | 955.47K | — | $2.61M | 0.0% | n/c | 1 | SEC ↗ |
| 82 | Bank of New York Mellon Corp | 955.47K | — | $2.61M | 0.0% | n/c | 1 | SEC ↗ |
| 83 | UBS Group AG | 764.15K | — | $2.09M | 0.0% | n/c | 1 | SEC ↗ |
| 84 | UBS Group AG | 764.15K | — | $2.09M | 0.0% | n/c | 1 | SEC ↗ |
| 85 | UBS Group AG | 764.15K | — | $2.09M | 0.0% | n/c | 1 | SEC ↗ |
| 86 | UBS Group AG | 764.15K | — | $2.09M | 0.0% | n/c | 1 | SEC ↗ |
| 87 | Aberdeen Group plc | 759.52K | — | $2.07M | 0.0% | n/c | 1 | SEC ↗ |
| 88 | Deutsche Bank Ag\ | 690.42K | — | $1.88M | 0.0% | n/c | 1 | SEC ↗ |
| 89 | Deutsche Bank Ag\ | 690.42K | — | $1.88M | 0.0% | n/c | 1 | SEC ↗ |
| 90 | Renaissance Technologies ✦ | 651.00K | Nieuw | $1.78M | 0.0% | New | 1 | SEC ↗ |
| 91 | Healthcare Of Ontario Pension Plan… | 628.54K | — | $1.72M | 0.0% | n/c | 1 | SEC ↗ |
| 92 | LPL Financial LLC | 623.07K | — | $1.70M | 0.0% | n/c | 1 | SEC ↗ |
| 93 | Royal Bank Of Canada | 608.46K | — | $1.66M | 0.0% | n/c | 1 | SEC ↗ |
| 94 | Royal Bank Of Canada | 608.46K | — | $1.66M | 0.0% | n/c | 1 | SEC ↗ |
| 95 | Royal Bank Of Canada | 608.46K | — | $1.66M | 0.0% | n/c | 1 | SEC ↗ |
| 96 | Royal Bank Of Canada | 608.46K | — | $1.66M | 0.0% | n/c | 1 | SEC ↗ |
| 97 | Royal Bank Of Canada | 608.46K | — | $1.66M | 0.0% | n/c | 1 | SEC ↗ |
| 98 | Swiss National Bank | 606.46K | — | $1.66M | 0.0% | n/c | 1 | SEC ↗ |
| 99 | Qube Research & Technologies Ltd | 564.52K | — | $1.54M | 0.0% | n/c | 1 | SEC ↗ |
| 100 | UBS AM, a distinct business unit of… | 469.71K | — | $1.28M | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $1.78M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 282 houders, 266.49M aandelen, $901.79M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Aug 07
SC 13G — STATE STREET CORP
Jul 28
SC 13G/A — BlackRock, Inc.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q4 2025 ·
Methodologie ·
Verkrijg dit via de API